Biography
Biography: Hossein Tabriziani
Abstract
"Incidence of End Stage Renal Failure is rising in US. By the year 2030, the number of patients with end-stage renal disease (ESRD) is projected to exceed 2.2 million. This is more than five times the current prevalence. Increasing in Kidney disease and subsequently ESRD is related to ageing of the society and high morbidity due to lifestyle diseases such as diabetes, atherosclerosis, and hypertension. During the past decade, kidney transplantation has increasingly been recognized as the treatment of choice for medically suitable patients with ESRD. As well as improving quality of life, successful transplantation accords major benefits by improving mortality and morbidity of ESRD patients who receive kidney transplant over those who undergo Renal Replacement Therapy (RRT). Although reducing Cardiovascular (CV) risk in these patients remains the leading cause of this improvement but still CV diseases remain the leading cause of morbidity and mortality in kidney transplant recipients.